Quadruple versus dual tacrolimus-based induction after liver transplantation: A prospective, randomized trial

Transplantation Proceedings

Volumn 33, Issue 3, 2001, Pages 2330-2331

  Langrehr, J M ^a   Klupp, J ^a   Junge, G ^a   Jonas, S ^a   Neuhaus, R ^a   Bechstein, W O ^a   Neuhaus, P ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; OKT 3; PREDNISOLONE; TACROLIMUS;

ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; DRUG COMBINATION; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOLOGY; LIVER TRANSPLANTATION; MORTALITY; MYCOSIS; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SURVIVAL RATE; TIME;

ANTILYMPHOCYTE SERUM; AZATHIOPRINE; BACTERIAL INFECTIONS; CYTOMEGALOVIRUS INFECTIONS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MUROMONAB-CD3; MYCOSES; POSTOPERATIVE COMPLICATIONS; PREDNISOLONE; PROSPECTIVE STUDIES; SEPSIS; SURVIVAL RATE; TACROLIMUS; TIME FACTORS;

EID: 0035345490     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(01)02011-5     Document Type: Article

References (2)

1. European FK506 Multicentre Liver Study Group. Lancet 344:423, 1994
2. The US Multicenter FK506 Liver Study Group. N Eng J Med 331:1110, 1994